2-(3-Ethoxy-4-Ethoxycarbonylphenyl)acetic Acid CAS 99469-99-5 Repaglinide Intermediate Purity >99.0% (HPLC)
Ruifu Chemical is the leading manufacturer of 2-(3-Ethoxy-4-Ethoxycarbonylphenyl)acetic Acid (CAS: 99469-99-5) with high quality. Ruifu Chemical can provide worldwide delivery, competitive price, excellent service, small and bulk quantities available. Purchase Repaglinide Intermediates, Please contact: alvin@ruifuchem.com
Chemical Name | 2-(3-Ethoxy-4-Ethoxycarbonylphenyl)acetic Acid |
Synonyms | Ethyl 4-Carboxymethyl-2-Ethoxybenzoate; 4-Carboxymethyl-2-Ethoxybenzoic Acid Ethyl Ester; 3-Ethoxy-4-Ethoxycarbonyl Phenylacetic Acid; 3-Ethoxy-4-(Ethoxycarbonyl)phenylacetic Acid; 3-Ethoxy-4-(Ethoxycarbonyl)benzeneacetic Acid; 2-[(4-Ethoxycarbonyl)-3-Ethoxyphenyl] Acetic Acid; 4-Ethoxycarbonyl-3-Ethoxyphenylacetic Acid |
Impurity | Repaglinide Related Compound B; Repaglinide EP Impurity B |
Stock Status | In Stock, Commercial Production |
CAS Number | 99469-99-5 |
Molecular Formula | C13H16O5 |
Molecular Weight | 252.27 g/mol |
Melting Point | 78.0 to 82.0℃ |
Density | 1.191 |
Solubility | Soluble in Methanol |
COA & MSDS | Available |
Origin | Shanghai, China |
Brand | Ruifu Chemical |
Items | Specifications | Results |
Appearance | White to Off-White Crystalline Powder | Complies |
Melting Point | 78.0 to 82.0℃ | 80.5℃ |
Water by Karl Fischer | <1.00% | 0.21% |
Purity / Analysis Method | >99.0% (HPLC) | 99.57% |
Total Impurities | <1.00% | 0.43% |
1H NMR Spectrum | Consistent with Structure | Complies |
Conclusion | The product has been tested and complies with the given specifications |
Package: Fluorinated Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry and well-ventilated warehouse away from incompatible substances. Protect from light and moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery.
How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.
Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.
Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.
Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.
Factory Audit? Factory audit welcome. Please make an appointment in advance.
MOQ? No MOQ. Small order is acceptable.
Delivery Time? If within stock, three days delivery guaranteed.
Transportation? By Express (FedEx, DHL), by Air, by Sea.
Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.
Custom Synthesis? Can provide custom synthesis services to best fit your research needs.
Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Hazard Symbols Xi - Irritant
Risk Codes
41 - Risk of serious damage to eyes
Safety Description
S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S39 - Wear eye / face protection.
HS Code 2942000000
2-(3-Ethoxy-4-Ethoxycarbonylphenyl)acetic Acid (CAS: 99469-99-5) is an intermediate / impurity of Repaglinide (CAS: 135062-02-1). Repaglinide was marketed in the US as an orally active hypoglycemic agent in patients with a type Ⅱ diabetes mellitus, to lower blood glucose in synergistic combination with metformin, when hyperglycemia cannot be controlled by diet, exercise or metformin alone. Repaglinide is a nonsulfonylurea insulin secretagogue that was introduced in the United States in 1998 for type 2 diabetes.